Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.48 |
| ▸ | DRD2 | P14416 | 2/20 | 0.48 |
| ▸ | DRD1 | P21728 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8415008 | 0.89 | GRIA2 (0.58) | CTBP2CYP3A4CYP1A2 | |
| SCHEMBL6509671 | 0.87 | ALDH1A1 (0.46) | CTBP2CYP1A2ALDH1A1 | |
| SCHEMBL30427127 | 0.83 | CTBP2 (0.59) | CTBP2ENPP2CHRM2CHRM1CHRM3 | |
| SCHEMBL22981807 | 0.83 | CTBP2 (0.59) | CTBP2ENPP2CHRM2CHRM1CHRM3 | |
| SCHEMBL7767320 | 0.83 | ENPP2 (0.56) | CTBP2ENPP2CHRM2CHRM1CHRM3 | |
| 3-Hydroxyphenylacetate SCHEMBL21114397 | 0.81 | CTBP2 (0.62) | CTBP2ENPP2DRD2DRD1TAAR1 | |
| 3-Hydroxyphenylacetate SCHEMBL30024342 | 0.81 | CTBP2 (0.62) | CTBP2ENPP2DRD2DRD1TAAR1 | |
| SCHEMBL21997278 | 0.81 | GRIA2 (0.50) | ENPP2ALDH1A1 | |
| 3-Hydroxyphenylacetate SCHEMBL337470 | 0.81 | CTBP2 (0.62) | CTBP2ENPP2DRD2DRD1TAAR1 | |
| 3-Hydroxyphenylacetate SCHEMBL30690861 | 0.81 | CTBP2 (0.62) | CTBP2ENPP2DRD2DRD1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118666696-A | Synthesis and refining method of meta-hydroxylamine bitartrate | 玉门千华制药有限公司 | 2024-09-20 | — | — | CN | claimed |
| EP-2619174-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | Ind-Swift Laboratories Limited (IN) | 2013-07-31 | — | — | EP | claimed |
| WO-2012038974-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | IND-SWIFT LABORATORIES LIMITED (IN) | 2012-03-29 | — | — | WO | claimed |
| CN-1882307-A | Method for dyeing fibres containing keratine | HENKEL KGAA (DE) | 2006-12-20 | — | — | CN | claimed |
| WO-1993010071-A1 | PROCESS FOR THE PRODUCTION OF CARBONYLS | CATALYTICA, INC. (US) | 1993-05-27 | — | — | WO | claimed |
| CN-118685463-B | Dapoxetine chiral intermediates of statins enzymatic synthesis of bodies | 杭州微远生物科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-118666695-B | Synthesis method of meta-hydroxylamine bitartrate | 玉门千华制药有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118685463-A | Dapoxetine chiral intermediates of statins enzymatic synthesis of bodies | 杭州微远生物科技有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118666695-A | Synthesis method of meta-hydroxylamine bitartrate | 玉门千华制药有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118666696-A | Synthesis and refining method of meta-hydroxylamine bitartrate | 玉门千华制药有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-117800802-A | Butanedione mediated benzyl C-H compound, halogeno compound, alkene, alkyne or alcohol oxidation method | 遵义医科大学 | 2024-04-02 | — | — | CN | disclosed |
| CN-111349076-B | Crystal form of L-lysine salt of benzopiperidine derivative and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2022-07-26 | — | — | CN | disclosed |
| US-5166210-A | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1992-11-24 | — | — | US | disclosed |
| US-5135863-A | Immunoassay; drug abuse | SYNTEX (U.S.A.) INC. (US) | 1992-08-04 | — | — | US | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-5028615-A | Treatment of hypersensitivity | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-07-02 | — | — | US | disclosed |
| EP-0375422-A2 | Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine | BEHRINGWERKE Aktiengesellschaft (DE) | 1990-06-27 | — | — | EP | disclosed |
| US-4920133-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| WO-1989004305-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-05-18 | — | — | WO | disclosed |